Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
McDonnell SE, et al. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol. Cell. Biol. 10: 4284-4293, 1990. PubMed: 2115124
Matrisian LM, et al. Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J. 4: 1435-1440, 1985. PubMed: 3875482
Kerr LD, et al. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 242: 1424-1427, 1988. PubMed: 2462278
Kerr LD, et al. Transforming growth factor beta1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin mRNA. J. Biol. Chem. 263: 16999-17005, 1988. PubMed: 2846555
Matrisian LM, et al. Differential expression of preproenkephalin and transin mRNAs following oncogenic transformation: evidence for two classes of oncogene induced genes. Oncogene Res. 2: 251-262, 1988. PubMed: 2835738
Matrisian LM, et al. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than benign tomors. Proc. Natl. Acad. Sci. USA 83: 9413-9417, 1986. PubMed: 3540938
Matrisian LM, et al. Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol. Cell. Biol. 6: 1679-1686, 1986. PubMed: 2431284
Breathnach R, et al. Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene. Nucleic Acids Res. 15: 1139-1151, 1987. PubMed: 3547333
<dfn id="wrbni"></dfn>